Circulation Journal Official Journal of the Japanese Circulation Society http://www. j-circ.or.jp ebate over the use of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) to treat ischemic heart disease has continued over several decades. The PCI procedure has shifted from balloon angioplasty into the stent era, and the development of drugeluting stents (DES), in particular, has ushered in a new era for surgeons. At the same time, in recent years stable results have been obtained using CABG procedures and we have entered the era of the less invasive, off-pump coronary artery bypass (OPCAB) procedure, the rate of use of which exceeds 60% in Japan, and good surgical results have been reported. 1 Regarding the selection of PCI or CABG, although many large-scale clinical trials have found no significant differences in actuarial survival, significant differences have been observed in major adverse cardiac and cerebrovascular events (MACCE) and repeat revascularization rates, and because of the complicated combinations of various factors, such as 3-vessel lesions, left main coronary artery disease, complex multivessel lesions, diabetes mellitus (DM), and kidney disease, debate over the selection of treatment for individual patients will continue. Here we discuss the CABG procedures, including OPCAB, based on previous clinical studies.
Findings Regarding Coronary RevascularizationBased on Treatment Method
Medical Treatment vs PCIIn comparisons of conservative medical treatment and PCI for treating stable coronary artery disease, meta-analyses performed in 11 randomized controlled trials (RCTs) conducted in 2005 with 2,950 subjects (wherein 1,476 received PCI and 1,474 received conservative treatment) revealed no significant differences in mortality, myocardial infarction (MI) and repeat revascularization rates between the 2 treatments. 2 In the subsequent COURAGE trial of 2007 with 2,287 subjects, an optimal medical therapy (MT) group (1,138 patients) and PCI with MT group (1,149 patients) were compared for longterm follow-up results (median: 4.6 years), and no significant differences were observed in hard endpoints such as death, MI and stroke. 3 However, it was reported that in the PCI group the improvement effects for the onset of angina pectoris were good, and single-photon-emission computed tomography (SPECT) examinations revealed significant improvement effects for patients with moderate to severe pretreatment ischemia. 4 On the other hand, in the JSAP study, 5 which was a multicenter RCT conducted in Japan with 384 subjects, an Coronary artery bypass graft (CABG) surgery is still the best therapy for patients with multivessel and left main coronary artery disease. Recently, the introduction of percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in these patients has improved the restenosis rate compared with bare metal stents. Furthermore, according to the results of the SYNTAX trial, no differences were found in the frequencies of mortality or myocardial infarcti...